LGALS9 and arthritic joint disease: Arikawa et al. reported that treatment with Gal-9 in an arthritis model repressed macrophage activity, resulting in the reduction of proinflammatory cytokine expression and the upregulation of anti-inflammatory cytokine expression [27].